Aptamer-mediated therapeutic strategies provide a potential approach for cancer
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112356 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Bingshuo Yan und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, People's Republic of China. Hauptthemen laut MEDLINE: Neoplasms, Aptamers, Nucleotide, Immunotherapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 132 Literaturangaben. Gefördert von: Anhui University of Chinese Medicine.
Abstract (Originalsprache)
The treatment of tumors still faces considerable challenges. While conventional treatments such as surgery, chemotherapy, and radiation therapy provide some curative effects, their side effects and limitations highlight the importance of finding more precise treatment strategies. Aptamers have become an important target molecule in the field of drug delivery systems due to their good affinity and targeting, and they have gradually become an important link from basic research to clinical application. In this paper, we discussed the latest progress of aptamer-mediated nanodrugs, as well as aptamer-mediated photodynamic therapy, photothermal therapy, and immunotherapy strategies for tumor treatment, and explored the possibility of aptamer-mediated therapy for accurate tumor treatment. The purpose of this review is to provide novel insights for treating tumors with aptamer-mediated therapies by summarizing these innovative strategies, thereby ultimately enhancing the therapeutic efficacy for cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, People's Republic of China.
- School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, People's Republic of China. Electronic address: hesm@ahtcm.edu.cn.
Förderung
- Anhui University of Chinese Medicine
Zitieren
APA
Yan, B., Li, Y., & He, S. (2024). Aptamer-mediated therapeutic strategies provide a potential approach for cancer. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112356
Vancouver
Yan B, Li Y, He S. Aptamer-mediated therapeutic strategies provide a potential approach for cancer. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112356
BibTeX
@article{Yan2024,
author = {Yan, Bingshuo and Li, Yuting and He, Shiming},
title = {Aptamer-mediated therapeutic strategies provide a potential approach for cancer},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112356}
}
EUVIMED